Market evolution: Isotope compounds (CN 2845) — 2015–2025

Introduction

CN 2845 covers non-radioactive isotopes and their inorganic or organic compounds, including heavy water (deuterium oxide), boron-10, lithium-6, helium-3, and other stable isotope products. These materials are strategically important across multiple sectors: nuclear energy, medical diagnostics and therapeutics, semiconductor manufacturing, and scientific research.

Between 2015 and 2025, the EU's trade in this product category underwent a dramatic transformation. Total import values rose by 524% and export values by 957%, driven predominantly by surging unit prices rather than volume growth. At the same time, the EU's net import reliance climbed from 12% to over 61%, signalling a fundamental shift in the bloc's structural position in this market. This report examines three principal dynamics that shaped the market over the decade.

1. Price-Driven Value Explosion Outpaces Volume Growth

Trade values surged far faster than physical volumes

The most striking feature of the 2015–2025 period is the divergence between value and quantity trajectories. EU exports rose from €25.4 million to €268.4 million in value (+957%), while physical export volumes grew from 38.8 tonnes to 106.5 tonnes (+175%). EU imports followed a similar pattern: values climbed from €46.0 million to €287.3 million (+524%), but quantities only increased from 47.2 tonnes to 83.5 tonnes (+77%).

Unit prices roughly tripled across the decade

The general overview shows that import prices rose from approximately €968,000 per tonne to €3.4 million per tonne, and export prices from €643,000 to €2.5 million per tonne. This implies that the underlying product mix shifted towards higher-value specialised isotopes, and/or that global supply constraints and rising demand — particularly from the nuclear, medical, and defence sectors — pushed prices upward.

The product segment that dominates trade is a heterogeneous "other isotopes" category

Breaking down imports by sub-category reveals that CN 284590 ("other non-radioactive isotopes") accounts for the overwhelming share of both imports and exports. In 2025, imports under 284590 were valued at €261.0 million (51.6 tonnes), with a unit price of approximately €5.0 million per tonne — the highest across all sub-lines and up from €1.2 million/tonne in 2015. Heavy water (CN 284510) is the second-largest category by value (€16.3 million imported in 2025), with more modest unit prices around €626,000/tonne.

Notably, Helium-3, Boron-10, and Lithium-6 only appear in the data from 2022 onwards, suggesting either newly emerging trade flows or a change in reporting granularity. These sub-products are associated with nuclear fusion research (Helium-3, Lithium-6) and neutron-absorption applications (Boron-10), consistent with the EU's growing strategic interest in fusion energy and nuclear technologies.

2. A Radically Reconfigured Geographic Landscape

China, Russia, and India emerged as dominant import suppliers

The partner data reveals a profound reconfiguration of the EU's import supply base. While the United States remained the largest single supplier throughout (€92.5 million in 2025), three partners underwent extraordinary growth:

China's surge — from a marginal supplier to nearly matching the United States — is particularly noteworthy. It likely reflects China's expanding role in isotope enrichment and chemical processing, potentially including stable isotopes used in medical imaging and electronics. The United Kingdom's sharp decline (−76%) may partly reflect post-Brexit trade restructuring, with flows potentially rerouted through other EU member states or replaced by alternative suppliers.

Ireland became the EU's largest exporter by a wide margin

On the export side, the most dramatic shift is Ireland's emergence as the dominant EU exporter. Irish exports surged from just over €1,000 in 2015 to €159.7 million in 2025 — accounting for roughly 59% of all EU extra-EU exports by value. At its peak (around 2020–2021), Ireland's exports reached approximately €1.34 billion. This is almost certainly linked to pharmaceutical and biotechnology manufacturing: Ireland hosts major production facilities for multinational companies, and stable isotopes are critical inputs for positron emission tomography (PET) tracers and other radiopharmaceutical precursors.

Import concentration decreased while export concentration rose

The Herfindahl-Hirschman Index (HHI) for imports declined from 3,060 to 2,511 (−18%), indicating that the EU diversified its import sources over the decade. Conversely, the export HHI rose from 1,605 to 2,617 (+63%), reflecting increasing concentration — driven primarily by Ireland's outsized and growing share. This asymmetry is structurally significant: while the EU broadened its supplier base on the import side, its export capacity became heavily dependent on a single member state.

Price volatility varied sharply across partners

The volatility analysis reveals that some supply relationships are considerably more stable than others. The United States (coefficient of variation of 0.27) and Canada (0.39) show relatively stable import flows, whereas imports from the United Kingdom (CV 1.42), India (1.82), and Russia (1.32) were highly volatile. On the export side, the United Kingdom (0.27) and Japan (0.37) were stable destinations, while Argentina (2.22) and Morocco (2.91) showed extreme variability.

3. Strategic Vulnerability Deepens as Domestic Capacity Erodes

Net import reliance quadrupled, reaching 61% by 2025

Perhaps the most consequential trend is the sharp rise in the EU's net import reliance, which climbed from 12.0% in 2015 to 61.1% in 2025 (+409%). At its lowest point (approximately 6.6%), the EU was close to self-sufficient in this category. The reversal to heavy dependence on imports occurred progressively from 2019 onwards and accelerated sharply after 2022.

EU domestic production collapsed in both volume and value

The production data tells a stark story: domestic production volumes fell from 200,000 kg to 40,000 kg (−80%), while production values declined from €65.0 million to €40.4 million (−38%). The fact that value fell less sharply than volume implies that what remains of EU production is concentrated in higher-value specialty isotope products, while lower-value or bulk production has either ceased or moved offshore.

Trade intensity surged, confirming the EU's shift to import dependence

The EU's trade intensity — the ratio of trade flows to domestic production — rose from 42.5% to 673.8% (+1,486%). Meanwhile, export propensity — exports as a share of production — climbed from 22.0% to 3,632.3%. These extreme ratios indicate that the EU's export profile is now largely decoupled from domestic primary production: much of what is exported likely originates from imported inputs that are processed, transformed, or re-exported within the EU (Ireland's pharmaceutical operations being the prime example).

A small number of EU member states specialise in this market

The specialisation analysis confirms that isotope trade is geographically concentrated within the EU. Portugal (RSCA 0.84, RCA 11.6), France (RSCA 0.45, RCA 2.6), and the Netherlands (RSCA 0.23, RCA 1.6) display clear comparative advantages. At the other extreme, Poland, Luxembourg, Greece, Lithuania, and Denmark show no meaningful specialisation in this product category. This concentration raises questions about intra-EU supply resilience: should specialised producing or processing member states face disruptions, there is limited capacity elsewhere in the bloc to compensate.

Conclusion

The EU's trade in non-radioactive isotopes (CN 2845) underwent a profound structural transformation between 2015 and 2025. What was once a relatively modest market characterised by near self-sufficiency has become a high-value, import-dependent sector with trade flows exceeding half a billion euros annually. Three defining features stand out:

1. Prices, not volumes, drove the value explosion. Unit prices roughly tripled over the decade, reflecting tightening global supply, rising demand from healthcare and energy sectors, and a compositional shift towards higher-value specialty isotopes.

2. The geographic map was redrawn. China, Russia, and India emerged as major import sources, while Ireland — through its pharmaceutical manufacturing base — became the EU's dominant exporter. The UK's role diminished sharply on the import side.

3. Strategic vulnerability has deepened significantly. With domestic production down 80% by volume and net import reliance at 61%, the EU is considerably more exposed to external supply disruptions than it was a decade ago. The concentration of export capacity in a single member state (Ireland) adds an additional layer of intra-EU fragility.

Looking ahead, the emergence of Helium-3, Boron-10, and Lithium-6 in recent trade data suggests that fusion energy and advanced nuclear applications are beginning to shape demand patterns — a development that could further intensify the EU's need for secure and diversified isotope supply chains.